Next-generation sequencing's biologics safety testing commercial disruption — the application of metagenomic NGS technology to biopharmaceutical adventitious agent detection — enabling unbiased, comprehensive screening for any potential viral, bacterial, or mycoplasma contamination in biological drug products without the limitations of targeted PCR or culture methods that can only...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
French
Spanish
Italiano
Romaian
Portuguese (Brazil)
china